<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"	
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	xmlns:media="http://search.yahoo.com/mrss/"
	>
<channel>
	<title>The Doctor&#039;s Channel</title>
	<atom:link href="http://www.thedoctorschannel.com/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.thedoctorschannel.com</link>
	<description>Short Vids for Doctors</description>
	<lastBuildDate>Fri, 17 May 2013 22:24:08 +0000</lastBuildDate>
	<language>en-us</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.4.1</generator>
			<item>
		<title>Antipyretics don&#8217;t slow children&#8217;s recovery &#8211; study</title>
		<link>http://www.thedoctorschannel.com/view/antipyretics-dont-slow-childrens-recovery-study/</link>
		<pubDate>Fri, 17 May 2013 22:24:08 +0000</pubDate> 
				<category><![CDATA[Reuters Health News]]></category>
		<category><![CDATA[Antipyretic, NOS]]></category>
		<category><![CDATA[Body temperature finding]]></category>
		<category><![CDATA[Central nervous system agent, NOS]]></category>
		<category><![CDATA[Convulsion, NOS]]></category>
		<category><![CDATA[Drug, NOS]]></category>
		<category><![CDATA[Febrile convulsion]]></category>
		<category><![CDATA[Finding by function]]></category>
		<category><![CDATA[Finding, conclusion AND/OR assessment]]></category>
		<category><![CDATA[General patient finding]]></category>
		<category><![CDATA[Generic drug, hormone, vitamin AND/OR blood product]]></category>
		<category><![CDATA[Increased body temperature]]></category>
		<category><![CDATA[Neurological sign or symptom, NOS]]></category>
		<category><![CDATA[SNOMED RT Concepts]]></category>
		<category><![CDATA[SNOMeSH]]></category>
		<category><![CDATA[Substance]]></category>
		<category><![CDATA[Vital signs finding]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/view/antipyretics-dont-slow-childrens-recovery-study/</guid>
		<description><![CDATA[By Trevor Stokes NEW YORK (Reuters Health) &#8211; A review of past research finds that antipyretics don&#8217;t slow children&#8217;s recovery from infection, contrary to the fears of some doctors and parents. Researchers have debated for decades whether lowering a sick child&#8217;s fever helps the recovery process, or interferes with it. Some previous research has shown -]]></description>
		
			<media:content duration="" medium="video">
		<media:title><![CDATA[Antipyretics don&#8217;t slow children&#8217;s recovery &#8211; study]]></media:title>
	<media:description><![CDATA[By Trevor Stokes NEW YORK (Reuters Health) &#8211; A review of past research finds that antipyretics don&#8217;t slow children&#8217;s recovery from infection, contrary to the fears of some doctors and parents. Researchers have debated for decades whether lowering a sick child&#8217;s fever helps the recovery process, or interferes with it. Some previous research has shown -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/antipyretics-dont-slow-childrens-recovery-study/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/04/tdc-textless-logo-120.jpg"/>
	<media:keywords><![CDATA[Antipyretic, NOS,Body temperature finding,Central nervous system agent, NOS,Convulsion, NOS,Drug, NOS,Febrile convulsion,Finding by function,Finding, conclusion AND/OR assessment,General patient finding,Generic drug, hormone, vitamin AND/OR blood product,Increased body temperature,Neurological sign or symptom, NOS,SNOMED RT Concepts,SNOMeSH,Substance,Vital signs finding]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>Higher-stakes soccer matches tied to more injuries</title>
		<link>http://www.thedoctorschannel.com/view/higher-stakes-soccer-matches-tied-to-more-injuries/</link>
		<pubDate>Fri, 17 May 2013 22:15:08 +0000</pubDate> 
				<category><![CDATA[Reuters Health News]]></category>
		<category><![CDATA[Behavior AND/OR conation finding]]></category>
		<category><![CDATA[Body structure]]></category>
		<category><![CDATA[Damage, NOS]]></category>
		<category><![CDATA[Engaged in non-contact physical sport]]></category>
		<category><![CDATA[Engaged in physical activity, NOS]]></category>
		<category><![CDATA[Engaged in physical sport, NOS]]></category>
		<category><![CDATA[Engaged in soccer]]></category>
		<category><![CDATA[Engaged in sports activity, NOS]]></category>
		<category><![CDATA[Finding by function]]></category>
		<category><![CDATA[Finding, conclusion AND/OR assessment]]></category>
		<category><![CDATA[Injury, NOS]]></category>
		<category><![CDATA[Morphologic abnormality, NOS]]></category>
		<category><![CDATA[Morphologically altered structure]]></category>
		<category><![CDATA[Physical agent, activity AND/OR force]]></category>
		<category><![CDATA[Psychological finding]]></category>
		<category><![CDATA[SNOMED RT Concepts]]></category>
		<category><![CDATA[SNOMeSH]]></category>
		<category><![CDATA[Soccer]]></category>
		<category><![CDATA[Sports activity, NOS]]></category>
		<category><![CDATA[Sports injury, NOS]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/view/higher-stakes-soccer-matches-tied-to-more-injuries/</guid>
		<description><![CDATA[By Kerry Grens NEW YORK (Reuters Health) &#8211; Soccer matches played at a high level of competition are more likely to result in injuries &#8211; and in more serious ones &#8211; compared to less important games, according to a new study. The finding makes sense, according to Håkan Bengtsson, who led the research, because prestigious -]]></description>
		
			<media:content duration="" medium="video">
		<media:title><![CDATA[Higher-stakes soccer matches tied to more injuries]]></media:title>
	<media:description><![CDATA[By Kerry Grens NEW YORK (Reuters Health) &#8211; Soccer matches played at a high level of competition are more likely to result in injuries &#8211; and in more serious ones &#8211; compared to less important games, according to a new study. The finding makes sense, according to Håkan Bengtsson, who led the research, because prestigious -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/higher-stakes-soccer-matches-tied-to-more-injuries/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/04/tdc-textless-logo-120.jpg"/>
	<media:keywords><![CDATA[Behavior AND/OR conation finding,Body structure,Damage, NOS,Engaged in non-contact physical sport,Engaged in physical activity, NOS,Engaged in physical sport, NOS,Engaged in soccer,Engaged in sports activity, NOS,Finding by function,Finding, conclusion AND/OR assessment,Injury, NOS,Morphologic abnormality, NOS,Morphologically altered structure,Physical agent, activity AND/OR force,Psychological finding,SNOMED RT Concepts,SNOMeSH,Soccer,Sports activity, NOS,Sports injury, NOS]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>Endometriosis more common in lean women: study</title>
		<link>http://www.thedoctorschannel.com/view/endometriosis-more-common-in-lean-women-study/</link>
		<pubDate>Fri, 17 May 2013 22:11:08 +0000</pubDate> 
				<category><![CDATA[Reuters Health News]]></category>
		<category><![CDATA[Analytical, Diagnostic and Therapeutic Techniques and Equipment (MeSH Category)]]></category>
		<category><![CDATA[Biological Sciences (MeSH Category)]]></category>
		<category><![CDATA[Body structure]]></category>
		<category><![CDATA[Cohort Studies]]></category>
		<category><![CDATA[Disease by body site]]></category>
		<category><![CDATA[Disease of female genital organs, NOS]]></category>
		<category><![CDATA[Disease of pelvis]]></category>
		<category><![CDATA[Disease of the genitourinary system, NOS]]></category>
		<category><![CDATA[Disease of trunk]]></category>
		<category><![CDATA[Disease, NOS]]></category>
		<category><![CDATA[Endometriosis, NOS]]></category>
		<category><![CDATA[Environment and Public Health]]></category>
		<category><![CDATA[Epidemiologic Methods]]></category>
		<category><![CDATA[Epidemiologic Studies]]></category>
		<category><![CDATA[Epidemiologic Study Characteristics]]></category>
		<category><![CDATA[Female infertility, NOS]]></category>
		<category><![CDATA[Female reproductive finding]]></category>
		<category><![CDATA[Fertility problem, NOS]]></category>
		<category><![CDATA[Finding by function]]></category>
		<category><![CDATA[Finding, conclusion AND/OR assessment]]></category>
		<category><![CDATA[Growth alteration, NOS]]></category>
		<category><![CDATA[health]]></category>
		<category><![CDATA[Health Care (MeSH Category)]]></category>
		<category><![CDATA[Health Care Evaluation Mechanisms]]></category>
		<category><![CDATA[Health Care Quality, Access, and Evaluation]]></category>
		<category><![CDATA[Health Occupations]]></category>
		<category><![CDATA[Health Services Administration]]></category>
		<category><![CDATA[Infertility, NOS]]></category>
		<category><![CDATA[Investigative Techniques]]></category>
		<category><![CDATA[Longitudinal Studies]]></category>
		<category><![CDATA[medicine]]></category>
		<category><![CDATA[MeSH Categories]]></category>
		<category><![CDATA[Metabolic disease, NOS]]></category>
		<category><![CDATA[Morphologic abnormality, NOS]]></category>
		<category><![CDATA[Morphologically altered structure]]></category>
		<category><![CDATA[Nutritional disorder, NOS]]></category>
		<category><![CDATA[Obesity, NOS]]></category>
		<category><![CDATA[Population Characteristics]]></category>
		<category><![CDATA[preventive medicine]]></category>
		<category><![CDATA[Proliferation, NOS]]></category>
		<category><![CDATA[Prospective Studies]]></category>
		<category><![CDATA[public health]]></category>
		<category><![CDATA[Quality of Health Care]]></category>
		<category><![CDATA[Reproductive finding]]></category>
		<category><![CDATA[Sexuality reproductive finding]]></category>
		<category><![CDATA[SNOMED RT Concepts]]></category>
		<category><![CDATA[SNOMeSH]]></category>
		<category><![CDATA[Specialties, Medical]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/view/endometriosis-more-common-in-lean-women-study/</guid>
		<description><![CDATA[By Genevra Pittman NEW YORK (Reuters Health) &#8211; Heavy women are less likely than slim women to be diagnosed with endometriosis, a new study shows. Researchers following more than 116,000 women found that morbidly obese study participants were 39% less likely than normal-weight women to develop the condition. That link was especially strong among infertile -]]></description>
		
			<media:content duration="" medium="video">
		<media:title><![CDATA[Endometriosis more common in lean women: study]]></media:title>
	<media:description><![CDATA[By Genevra Pittman NEW YORK (Reuters Health) &#8211; Heavy women are less likely than slim women to be diagnosed with endometriosis, a new study shows. Researchers following more than 116,000 women found that morbidly obese study participants were 39% less likely than normal-weight women to develop the condition. That link was especially strong among infertile -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/endometriosis-more-common-in-lean-women-study/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/04/tdc-textless-logo-120.jpg"/>
	<media:keywords><![CDATA[Analytical, Diagnostic and Therapeutic Techniques and Equipment (MeSH Category),Biological Sciences (MeSH Category),Body structure,Cohort Studies,Disease by body site,Disease of female genital organs, NOS,Disease of pelvis,Disease of the genitourinary system, NOS,Disease of trunk,Disease, NOS,Endometriosis, NOS,Environment and Public Health,Epidemiologic Methods,Epidemiologic Studies,Epidemiologic Study Characteristics,Female infertility, NOS,Female reproductive finding,Fertility problem, NOS,Finding by function,Finding, conclusion AND/OR assessment,Growth alteration, NOS,health,Health Care (MeSH Category),Health Care Evaluation Mechanisms,Health Care Quality, Access, and Evaluation,Health Occupations,Health Services Administration,Infertility, NOS,Investigative Techniques,Longitudinal Studies,medicine,MeSH Categories,Metabolic disease, NOS,Morphologic abnormality, NOS,Morphologically altered structure,Nutritional disorder, NOS,Obesity, NOS,Population Characteristics,preventive medicine,Proliferation, NOS,Prospective Studies,public health,Quality of Health Care,Reproductive finding,Sexuality reproductive finding,SNOMED RT Concepts,SNOMeSH,Specialties, Medical]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>Initial response to nicotine patch helps tailor smoking cessation treatment</title>
		<link>http://www.thedoctorschannel.com/view/initial-response-to-nicotine-patch-helps-tailor-smoking-cessation-treatment/</link>
		<pubDate>Fri, 17 May 2013 22:00:08 +0000</pubDate> 
				<category><![CDATA[Reuters Health News]]></category>
		<category><![CDATA[Algorithms]]></category>
		<category><![CDATA[Analytical, Diagnostic and Therapeutic Techniques and Equipment (MeSH Category)]]></category>
		<category><![CDATA[Antidepressant, NOS]]></category>
		<category><![CDATA[Behavior, NOS]]></category>
		<category><![CDATA[Biological Sciences (MeSH Category)]]></category>
		<category><![CDATA[Biological substance]]></category>
		<category><![CDATA[Bupropion]]></category>
		<category><![CDATA[Central nervous system agent, NOS]]></category>
		<category><![CDATA[clinical trials]]></category>
		<category><![CDATA[Computing Methodologies]]></category>
		<category><![CDATA[Drug, NOS]]></category>
		<category><![CDATA[Environment and Public Health]]></category>
		<category><![CDATA[Epidemiologic Methods]]></category>
		<category><![CDATA[Epidemiologic Study Characteristics]]></category>
		<category><![CDATA[Evaluation Studies]]></category>
		<category><![CDATA[Finding by function]]></category>
		<category><![CDATA[Finding, conclusion AND/OR assessment]]></category>
		<category><![CDATA[Generic drug, hormone, vitamin AND/OR blood product]]></category>
		<category><![CDATA[health]]></category>
		<category><![CDATA[Health Care (MeSH Category)]]></category>
		<category><![CDATA[Health Care Evaluation Mechanisms]]></category>
		<category><![CDATA[Health Care Quality, Access, and Evaluation]]></category>
		<category><![CDATA[Health Occupations]]></category>
		<category><![CDATA[Health Services Administration]]></category>
		<category><![CDATA[Information Science]]></category>
		<category><![CDATA[Information Science (MeSH Category)]]></category>
		<category><![CDATA[Investigative Techniques]]></category>
		<category><![CDATA[Mathematics]]></category>
		<category><![CDATA[medical informatics]]></category>
		<category><![CDATA[Medical Informatics Computing]]></category>
		<category><![CDATA[medicine]]></category>
		<category><![CDATA[MeSH Categories]]></category>
		<category><![CDATA[Modifier, linkage term AND/OR qualifier]]></category>
		<category><![CDATA[nicotine]]></category>
		<category><![CDATA[Physical Sciences]]></category>
		<category><![CDATA[Physical Sciences (MeSH Category)]]></category>
		<category><![CDATA[Phytotoxin, NOS]]></category>
		<category><![CDATA[Plant product, NOS]]></category>
		<category><![CDATA[Population Characteristics]]></category>
		<category><![CDATA[preventive medicine]]></category>
		<category><![CDATA[Psychological finding]]></category>
		<category><![CDATA[Psychotherapeutic agent, NOS]]></category>
		<category><![CDATA[public health]]></category>
		<category><![CDATA[Quality of Health Care]]></category>
		<category><![CDATA[Randomized Controlled Trials]]></category>
		<category><![CDATA[Route of administration, NOS]]></category>
		<category><![CDATA[science]]></category>
		<category><![CDATA[smoking cessation]]></category>
		<category><![CDATA[SNOMED RT Concepts]]></category>
		<category><![CDATA[SNOMeSH]]></category>
		<category><![CDATA[Specialties, Medical]]></category>
		<category><![CDATA[Substance]]></category>
		<category><![CDATA[Tobacco Use Cessation]]></category>
		<category><![CDATA[Toxic chemical, NOS]]></category>
		<category><![CDATA[Toxin, NOS]]></category>
		<category><![CDATA[Transdermal route]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/view/initial-response-to-nicotine-patch-helps-tailor-smoking-cessation-treatment/</guid>
		<description><![CDATA[By Will Boggs, MD NEW YORK (Reuters Health) &#8211; A smoker&#8217;s initial response to nicotine patches &#8211; before the &#8220;quit date&#8221; &#8211; can help guide smoking cessation therapy and improve the likelihood of success, a new study suggests. &#8220;Different smokers benefit from different treatments,&#8221; Dr. Jed E. Rose from Duke University Medical Center, Durham, North -]]></description>
		
			<media:content duration="" medium="video">
		<media:title><![CDATA[Initial response to nicotine patch helps tailor smoking cessation treatment]]></media:title>
	<media:description><![CDATA[By Will Boggs, MD NEW YORK (Reuters Health) &#8211; A smoker&#8217;s initial response to nicotine patches &#8211; before the &#8220;quit date&#8221; &#8211; can help guide smoking cessation therapy and improve the likelihood of success, a new study suggests. &#8220;Different smokers benefit from different treatments,&#8221; Dr. Jed E. Rose from Duke University Medical Center, Durham, North -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/initial-response-to-nicotine-patch-helps-tailor-smoking-cessation-treatment/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/04/tdc-textless-logo-120.jpg"/>
	<media:keywords><![CDATA[Algorithms,Analytical, Diagnostic and Therapeutic Techniques and Equipment (MeSH Category),Antidepressant, NOS,Behavior, NOS,Biological Sciences (MeSH Category),Biological substance,Bupropion,Central nervous system agent, NOS,clinical trials,Computing Methodologies,Drug, NOS,Environment and Public Health,Epidemiologic Methods,Epidemiologic Study Characteristics,Evaluation Studies,Finding by function,Finding, conclusion AND/OR assessment,Generic drug, hormone, vitamin AND/OR blood product,health,Health Care (MeSH Category),Health Care Evaluation Mechanisms,Health Care Quality, Access, and Evaluation,Health Occupations,Health Services Administration,Information Science,Information Science (MeSH Category),Investigative Techniques,Mathematics,medical informatics,Medical Informatics Computing,medicine,MeSH Categories,Modifier, linkage term AND/OR qualifier,nicotine,Physical Sciences,Physical Sciences (MeSH Category),Phytotoxin, NOS,Plant product, NOS,Population Characteristics,preventive medicine,Psychological finding,Psychotherapeutic agent, NOS,public health,Quality of Health Care,Randomized Controlled Trials,Route of administration, NOS,science,smoking cessation,SNOMED RT Concepts,SNOMeSH,Specialties, Medical,Substance,Tobacco Use Cessation,Toxic chemical, NOS,Toxin, NOS,Transdermal route]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>Canadian astronaut wrestles with gravity after spaceflight</title>
		<link>http://www.thedoctorschannel.com/view/canadian-astronaut-wrestles-with-gravity-after-spaceflight/</link>
		<pubDate>Fri, 17 May 2013 21:48:08 +0000</pubDate> 
				<category><![CDATA[Reuters Health News]]></category>
		<category><![CDATA[Acclimation, NOS]]></category>
		<category><![CDATA[Adaptation, NOS]]></category>
		<category><![CDATA[Anthropology, Education, Sociology and Social Phenomena (MeSH Category)]]></category>
		<category><![CDATA[Astronauts]]></category>
		<category><![CDATA[Atrophy, NOS]]></category>
		<category><![CDATA[aviation]]></category>
		<category><![CDATA[Behavioral Disciplines and Activities]]></category>
		<category><![CDATA[Behavioral Sciences]]></category>
		<category><![CDATA[Biological function, NOS]]></category>
		<category><![CDATA[Body structure]]></category>
		<category><![CDATA[Degenerative abnormality]]></category>
		<category><![CDATA[Diseases (MeSH Category)]]></category>
		<category><![CDATA[government]]></category>
		<category><![CDATA[Government Agencies]]></category>
		<category><![CDATA[Gravitation]]></category>
		<category><![CDATA[Gravity, Altered]]></category>
		<category><![CDATA[Health Care (MeSH Category)]]></category>
		<category><![CDATA[Health Care Economics and Organizations]]></category>
		<category><![CDATA[MeSH Categories]]></category>
		<category><![CDATA[Morphologic abnormality, NOS]]></category>
		<category><![CDATA[Morphologically altered structure]]></category>
		<category><![CDATA[Muscular Atrophy]]></category>
		<category><![CDATA[Nervous System Diseases]]></category>
		<category><![CDATA[Neurologic Manifestations]]></category>
		<category><![CDATA[Neuromuscular Manifestations]]></category>
		<category><![CDATA[Occupational Groups]]></category>
		<category><![CDATA[Organizations]]></category>
		<category><![CDATA[Pathological Conditions, Signs and Symptoms]]></category>
		<category><![CDATA[Persons]]></category>
		<category><![CDATA[Persons (MeSH Category)]]></category>
		<category><![CDATA[Physical Sciences]]></category>
		<category><![CDATA[Physical Sciences (MeSH Category)]]></category>
		<category><![CDATA[Physics]]></category>
		<category><![CDATA[Psychiatry and Psychology (MeSH Category)]]></category>
		<category><![CDATA[Research Personnel]]></category>
		<category><![CDATA[Signs and Symptoms]]></category>
		<category><![CDATA[SNOMED RT Concepts]]></category>
		<category><![CDATA[SNOMeSH]]></category>
		<category><![CDATA[Social Sciences]]></category>
		<category><![CDATA[space flight]]></category>
		<category><![CDATA[Technology, Food and Beverages (MeSH Category)]]></category>
		<category><![CDATA[Technology, Industry, and Agriculture]]></category>
		<category><![CDATA[Transportation]]></category>
		<category><![CDATA[United States National Aeronautics and Space Administration]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/view/canadian-astronaut-wrestles-with-gravity-after-spaceflight/</guid>
		<description><![CDATA[By Irene Klotz CAPE CANAVERAL, Fla. (Reuters) &#8211; Back on Earth, Canadian astronaut and cyberspace tweeter Chris Hadfield is getting a rough re-introduction to gravity after a five-month stint aboard the International Space Station, the former commander told reporters during a video webcast from Houston. Hadfield became a social media rock star with his zero-gravity -]]></description>
		
			<media:content duration="" medium="video">
		<media:title><![CDATA[Canadian astronaut wrestles with gravity after spaceflight]]></media:title>
	<media:description><![CDATA[By Irene Klotz CAPE CANAVERAL, Fla. (Reuters) &#8211; Back on Earth, Canadian astronaut and cyberspace tweeter Chris Hadfield is getting a rough re-introduction to gravity after a five-month stint aboard the International Space Station, the former commander told reporters during a video webcast from Houston. Hadfield became a social media rock star with his zero-gravity -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/canadian-astronaut-wrestles-with-gravity-after-spaceflight/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/04/tdc-textless-logo-120.jpg"/>
	<media:keywords><![CDATA[Acclimation, NOS,Adaptation, NOS,Anthropology, Education, Sociology and Social Phenomena (MeSH Category),Astronauts,Atrophy, NOS,aviation,Behavioral Disciplines and Activities,Behavioral Sciences,Biological function, NOS,Body structure,Degenerative abnormality,Diseases (MeSH Category),government,Government Agencies,Gravitation,Gravity, Altered,Health Care (MeSH Category),Health Care Economics and Organizations,MeSH Categories,Morphologic abnormality, NOS,Morphologically altered structure,Muscular Atrophy,Nervous System Diseases,Neurologic Manifestations,Neuromuscular Manifestations,Occupational Groups,Organizations,Pathological Conditions, Signs and Symptoms,Persons,Persons (MeSH Category),Physical Sciences,Physical Sciences (MeSH Category),Physics,Psychiatry and Psychology (MeSH Category),Research Personnel,Signs and Symptoms,SNOMED RT Concepts,SNOMeSH,Social Sciences,space flight,Technology, Food and Beverages (MeSH Category),Technology, Industry, and Agriculture,Transportation,United States National Aeronautics and Space Administration]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>AstraZeneca accelerates cancer drug testing</title>
		<link>http://www.thedoctorschannel.com/view/astrazeneca-accelerates-cancer-drug-testing/</link>
		<pubDate>Fri, 17 May 2013 21:25:08 +0000</pubDate> 
				<category><![CDATA[Reuters Health News]]></category>
		<category><![CDATA[Analytical, Diagnostic and Therapeutic Techniques and Equipment (MeSH Category)]]></category>
		<category><![CDATA[Biological Sciences (MeSH Category)]]></category>
		<category><![CDATA[Bone marrow disorder]]></category>
		<category><![CDATA[clinical trials]]></category>
		<category><![CDATA[Clinical Trials, Phase III]]></category>
		<category><![CDATA[Congresses]]></category>
		<category><![CDATA[Disease by body site]]></category>
		<category><![CDATA[Disease of hematopoietic system, NOS]]></category>
		<category><![CDATA[Disease, NOS]]></category>
		<category><![CDATA[Drug, NOS]]></category>
		<category><![CDATA[Drugs, Investigational]]></category>
		<category><![CDATA[Environment and Public Health]]></category>
		<category><![CDATA[Epidemiologic Methods]]></category>
		<category><![CDATA[Epidemiologic Study Characteristics]]></category>
		<category><![CDATA[Evaluation Studies]]></category>
		<category><![CDATA[Finding, conclusion AND/OR assessment]]></category>
		<category><![CDATA[Generic drug, hormone, vitamin AND/OR blood product]]></category>
		<category><![CDATA[Hairy cell leukemia (clinical)]]></category>
		<category><![CDATA[health]]></category>
		<category><![CDATA[Health Care (MeSH Category)]]></category>
		<category><![CDATA[Health Care Economics and Organizations]]></category>
		<category><![CDATA[Health Care Evaluation Mechanisms]]></category>
		<category><![CDATA[Health Care Quality, Access, and Evaluation]]></category>
		<category><![CDATA[Health Occupations]]></category>
		<category><![CDATA[Health Services Administration]]></category>
		<category><![CDATA[Hematologic malignancy]]></category>
		<category><![CDATA[Hematologic neoplasm]]></category>
		<category><![CDATA[Investigative Techniques]]></category>
		<category><![CDATA[Leukemia, NOS, without mention of remission]]></category>
		<category><![CDATA[Malignant neoplasm of bone marrow, NOS]]></category>
		<category><![CDATA[Malignant neoplastic disease]]></category>
		<category><![CDATA[medicine]]></category>
		<category><![CDATA[MeSH Categories]]></category>
		<category><![CDATA[Neoplasm by body site]]></category>
		<category><![CDATA[Neoplastic disease, NOS]]></category>
		<category><![CDATA[Organizations]]></category>
		<category><![CDATA[Population Characteristics]]></category>
		<category><![CDATA[preventive medicine]]></category>
		<category><![CDATA[public health]]></category>
		<category><![CDATA[Quality of Health Care]]></category>
		<category><![CDATA[SNOMED RT Concepts]]></category>
		<category><![CDATA[SNOMeSH]]></category>
		<category><![CDATA[Specialties, Medical]]></category>
		<category><![CDATA[Substance]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/view/astrazeneca-accelerates-cancer-drug-testing/</guid>
		<description><![CDATA[By Ben Hirschler LONDON (Reuters) &#8211; AstraZeneca has enrolled the first patient into a phase III clinical trial to test moxetumomab pasudotox in patients with hairy cell leukemia who have not responded to or have relapsed after standard therapy. New Chief Executive Pascal Soriot has made accelerating the company&#8217;s cancer drug pipeline a priority. The -]]></description>
		
			<media:content duration="" medium="video">
		<media:title><![CDATA[AstraZeneca accelerates cancer drug testing]]></media:title>
	<media:description><![CDATA[By Ben Hirschler LONDON (Reuters) &#8211; AstraZeneca has enrolled the first patient into a phase III clinical trial to test moxetumomab pasudotox in patients with hairy cell leukemia who have not responded to or have relapsed after standard therapy. New Chief Executive Pascal Soriot has made accelerating the company&#8217;s cancer drug pipeline a priority. The -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/astrazeneca-accelerates-cancer-drug-testing/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/04/tdc-textless-logo-120.jpg"/>
	<media:keywords><![CDATA[Analytical, Diagnostic and Therapeutic Techniques and Equipment (MeSH Category),Biological Sciences (MeSH Category),Bone marrow disorder,clinical trials,Clinical Trials, Phase III,Congresses,Disease by body site,Disease of hematopoietic system, NOS,Disease, NOS,Drug, NOS,Drugs, Investigational,Environment and Public Health,Epidemiologic Methods,Epidemiologic Study Characteristics,Evaluation Studies,Finding, conclusion AND/OR assessment,Generic drug, hormone, vitamin AND/OR blood product,Hairy cell leukemia (clinical),health,Health Care (MeSH Category),Health Care Economics and Organizations,Health Care Evaluation Mechanisms,Health Care Quality, Access, and Evaluation,Health Occupations,Health Services Administration,Hematologic malignancy,Hematologic neoplasm,Investigative Techniques,Leukemia, NOS, without mention of remission,Malignant neoplasm of bone marrow, NOS,Malignant neoplastic disease,medicine,MeSH Categories,Neoplasm by body site,Neoplastic disease, NOS,Organizations,Population Characteristics,preventive medicine,public health,Quality of Health Care,SNOMED RT Concepts,SNOMeSH,Specialties, Medical,Substance]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>EU watchdog backs contraceptive drug for acne in certain patients</title>
		<link>http://www.thedoctorschannel.com/view/eu-watchdog-backs-contraceptive-drug-for-acne-in-certain-patients/</link>
		<pubDate>Fri, 17 May 2013 21:00:08 +0000</pubDate> 
				<category><![CDATA[Reuters Health News]]></category>
		<category><![CDATA[Acne product]]></category>
		<category><![CDATA[Analytical, Diagnostic and Therapeutic Techniques and Equipment (MeSH Category)]]></category>
		<category><![CDATA[Anthropology, Education, Sociology and Social Phenomena (MeSH Category)]]></category>
		<category><![CDATA[Behavioral Disciplines and Activities]]></category>
		<category><![CDATA[Behavioral Sciences]]></category>
		<category><![CDATA[Biological Sciences (MeSH Category)]]></category>
		<category><![CDATA[contraceptives]]></category>
		<category><![CDATA[Drug and Narcotic Control]]></category>
		<category><![CDATA[Drug Approval]]></category>
		<category><![CDATA[Drug, NOS]]></category>
		<category><![CDATA[Evaluation Studies]]></category>
		<category><![CDATA[Generic drug, hormone, vitamin AND/OR blood product]]></category>
		<category><![CDATA[Health Care (MeSH Category)]]></category>
		<category><![CDATA[Health Care Economics and Organizations]]></category>
		<category><![CDATA[Health Care Evaluation Mechanisms]]></category>
		<category><![CDATA[Health Care Quality, Access, and Evaluation]]></category>
		<category><![CDATA[Health Occupations]]></category>
		<category><![CDATA[Health Services Administration]]></category>
		<category><![CDATA[Hormone preparation, NOS]]></category>
		<category><![CDATA[Investigative Techniques]]></category>
		<category><![CDATA[legislation]]></category>
		<category><![CDATA[Legislation, Drug]]></category>
		<category><![CDATA[MeSH Categories]]></category>
		<category><![CDATA[Oral contraceptive preparation, NOS]]></category>
		<category><![CDATA[Organization and Administration]]></category>
		<category><![CDATA[Pharmacy Administration]]></category>
		<category><![CDATA[Psychiatry and Psychology (MeSH Category)]]></category>
		<category><![CDATA[Quality of Health Care]]></category>
		<category><![CDATA[Skin agent, NOS]]></category>
		<category><![CDATA[SNOMED RT Concepts]]></category>
		<category><![CDATA[SNOMeSH]]></category>
		<category><![CDATA[Social Control, Formal]]></category>
		<category><![CDATA[Social Sciences]]></category>
		<category><![CDATA[Sociology]]></category>
		<category><![CDATA[Substance]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/view/eu-watchdog-backs-contraceptive-drug-for-acne-in-certain-patients/</guid>
		<description><![CDATA[LONDON (Reuters) &#8211; Bayer&#8217;s oral contraceptive pill Diane 35 (cyproterone acetate 2 mg, ethinylestradiol 35 micrograms) and its generic versions are safe for treating acne in certain women when other options have failed, the European Medicines Agency said on Friday. Following a formal safety review, conducted at the request of French authorities, the agency concluded -]]></description>
		
			<media:content duration="" medium="video">
		<media:title><![CDATA[EU watchdog backs contraceptive drug for acne in certain patients]]></media:title>
	<media:description><![CDATA[LONDON (Reuters) &#8211; Bayer&#8217;s oral contraceptive pill Diane 35 (cyproterone acetate 2 mg, ethinylestradiol 35 micrograms) and its generic versions are safe for treating acne in certain women when other options have failed, the European Medicines Agency said on Friday. Following a formal safety review, conducted at the request of French authorities, the agency concluded -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/eu-watchdog-backs-contraceptive-drug-for-acne-in-certain-patients/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/04/tdc-textless-logo-120.jpg"/>
	<media:keywords><![CDATA[Acne product,Analytical, Diagnostic and Therapeutic Techniques and Equipment (MeSH Category),Anthropology, Education, Sociology and Social Phenomena (MeSH Category),Behavioral Disciplines and Activities,Behavioral Sciences,Biological Sciences (MeSH Category),contraceptives,Drug and Narcotic Control,Drug Approval,Drug, NOS,Evaluation Studies,Generic drug, hormone, vitamin AND/OR blood product,Health Care (MeSH Category),Health Care Economics and Organizations,Health Care Evaluation Mechanisms,Health Care Quality, Access, and Evaluation,Health Occupations,Health Services Administration,Hormone preparation, NOS,Investigative Techniques,legislation,Legislation, Drug,MeSH Categories,Oral contraceptive preparation, NOS,Organization and Administration,Pharmacy Administration,Psychiatry and Psychology (MeSH Category),Quality of Health Care,Skin agent, NOS,SNOMED RT Concepts,SNOMeSH,Social Control, Formal,Social Sciences,Sociology,Substance]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>Nonoperative management OK for isolated posterior cruciate ligament injuries</title>
		<link>http://www.thedoctorschannel.com/view/nonoperative-management-ok-for-isolated-posterior-cruciate-ligament-injuries/</link>
		<pubDate>Fri, 17 May 2013 20:00:08 +0000</pubDate> 
				<category><![CDATA[Reuters Health News]]></category>
		<category><![CDATA[Anatomical structure]]></category>
		<category><![CDATA[Biological Sciences (MeSH Category)]]></category>
		<category><![CDATA[Body organ, NOS]]></category>
		<category><![CDATA[Body structure]]></category>
		<category><![CDATA[Disease Management]]></category>
		<category><![CDATA[Health Care (MeSH Category)]]></category>
		<category><![CDATA[Health Occupations]]></category>
		<category><![CDATA[Health Services Administration]]></category>
		<category><![CDATA[Joint, NOS]]></category>
		<category><![CDATA[Ligament, NOS]]></category>
		<category><![CDATA[Ligaments, Articular]]></category>
		<category><![CDATA[MeSH Categories]]></category>
		<category><![CDATA[Patient Care Management]]></category>
		<category><![CDATA[Physical anatomical entity]]></category>
		<category><![CDATA[Posterior Cruciate Ligament]]></category>
		<category><![CDATA[SNOMED RT Concepts]]></category>
		<category><![CDATA[SNOMeSH]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/view/nonoperative-management-ok-for-isolated-posterior-cruciate-ligament-injuries/</guid>
		<description><![CDATA[By James E. Barone MD NEW YORK (Reuters Health) &#8211; In a series of patients with isolated posterior cruciate ligament (PCL) injuries followed for up to 17 years, nonoperative management yielded outcomes that compare favorably to published results for surgery. Lead author Dr. K. Donald Shelbourne said in an email to Reuters Health, &#8220;PCL reconstruction -]]></description>
		
			<media:content duration="" medium="video">
		<media:title><![CDATA[Nonoperative management OK for isolated posterior cruciate ligament injuries]]></media:title>
	<media:description><![CDATA[By James E. Barone MD NEW YORK (Reuters Health) &#8211; In a series of patients with isolated posterior cruciate ligament (PCL) injuries followed for up to 17 years, nonoperative management yielded outcomes that compare favorably to published results for surgery. Lead author Dr. K. Donald Shelbourne said in an email to Reuters Health, &#8220;PCL reconstruction -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/nonoperative-management-ok-for-isolated-posterior-cruciate-ligament-injuries/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/04/tdc-textless-logo-120.jpg"/>
	<media:keywords><![CDATA[Anatomical structure,Biological Sciences (MeSH Category),Body organ, NOS,Body structure,Disease Management,Health Care (MeSH Category),Health Occupations,Health Services Administration,Joint, NOS,Ligament, NOS,Ligaments, Articular,MeSH Categories,Patient Care Management,Physical anatomical entity,Posterior Cruciate Ligament,SNOMED RT Concepts,SNOMeSH]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>Cutaneous leishmaniasis can be cured without systemic therapy</title>
		<link>http://www.thedoctorschannel.com/view/cutaneous-leishmaniasis-can-be-cured-without-systemic-therapy/</link>
		<pubDate>Fri, 17 May 2013 19:45:08 +0000</pubDate> 
				<category><![CDATA[Reuters Health News]]></category>
		<category><![CDATA[Analytical, Diagnostic and Therapeutic Techniques and Equipment (MeSH Category)]]></category>
		<category><![CDATA[Anthropology, Education, Sociology and Social Phenomena (MeSH Category)]]></category>
		<category><![CDATA[Disease caused by parasite, NOS]]></category>
		<category><![CDATA[Disease, NOS]]></category>
		<category><![CDATA[Drug Therapy]]></category>
		<category><![CDATA[Finding, conclusion AND/OR assessment]]></category>
		<category><![CDATA[Human Activities]]></category>
		<category><![CDATA[Infectious disease, NOS]]></category>
		<category><![CDATA[Leishmaniasis]]></category>
		<category><![CDATA[Leishmaniasis, Cutaneous]]></category>
		<category><![CDATA[MeSH Categories]]></category>
		<category><![CDATA[Modifier, linkage term AND/OR qualifier]]></category>
		<category><![CDATA[Route of administration, NOS]]></category>
		<category><![CDATA[SNOMED RT Concepts]]></category>
		<category><![CDATA[SNOMeSH]]></category>
		<category><![CDATA[Therapeutics]]></category>
		<category><![CDATA[Topical route]]></category>
		<category><![CDATA[travel]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/view/cutaneous-leishmaniasis-can-be-cured-without-systemic-therapy/</guid>
		<description><![CDATA[By Will Boggs, MD NEW YORK (Reuters Health) &#8211; Travelers with cutaneous leishmaniasis can usually be cured without systemic therapy, according to results from the Cutaneous Leishmaniasis French Study Group. &#8220;When you do not know how to treat a patient with cutaneous leishmaniasis, get back to simple questions,&#8221; said Dr. Pierre A. Buffet from Institut -]]></description>
		
			<media:content duration="" medium="video">
		<media:title><![CDATA[Cutaneous leishmaniasis can be cured without systemic therapy]]></media:title>
	<media:description><![CDATA[By Will Boggs, MD NEW YORK (Reuters Health) &#8211; Travelers with cutaneous leishmaniasis can usually be cured without systemic therapy, according to results from the Cutaneous Leishmaniasis French Study Group. &#8220;When you do not know how to treat a patient with cutaneous leishmaniasis, get back to simple questions,&#8221; said Dr. Pierre A. Buffet from Institut -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/cutaneous-leishmaniasis-can-be-cured-without-systemic-therapy/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/04/tdc-textless-logo-120.jpg"/>
	<media:keywords><![CDATA[Analytical, Diagnostic and Therapeutic Techniques and Equipment (MeSH Category),Anthropology, Education, Sociology and Social Phenomena (MeSH Category),Disease caused by parasite, NOS,Disease, NOS,Drug Therapy,Finding, conclusion AND/OR assessment,Human Activities,Infectious disease, NOS,Leishmaniasis,Leishmaniasis, Cutaneous,MeSH Categories,Modifier, linkage term AND/OR qualifier,Route of administration, NOS,SNOMED RT Concepts,SNOMeSH,Therapeutics,Topical route,travel]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>Ranibizumab boosts reading speed in macular edema</title>
		<link>http://www.thedoctorschannel.com/view/ranibizumab-boosts-reading-speed-in-macular-edema/</link>
		<pubDate>Fri, 17 May 2013 18:45:08 +0000</pubDate> 
				<category><![CDATA[Reuters Health News]]></category>
		<category><![CDATA[Administration]]></category>
		<category><![CDATA[Administration of medication, NOS]]></category>
		<category><![CDATA[Biological agent, NOS]]></category>
		<category><![CDATA[Disease by body site]]></category>
		<category><![CDATA[Disease of eye, NOS]]></category>
		<category><![CDATA[Disease of head]]></category>
		<category><![CDATA[Disease, NOS]]></category>
		<category><![CDATA[Disorder of orbit, NOS]]></category>
		<category><![CDATA[Disorder of posterior segment of eye]]></category>
		<category><![CDATA[Drug, NOS]]></category>
		<category><![CDATA[Finding, conclusion AND/OR assessment]]></category>
		<category><![CDATA[Generic drug, hormone, vitamin AND/OR blood product]]></category>
		<category><![CDATA[Injection of anterior chamber of eye, NOS]]></category>
		<category><![CDATA[Injection of anterior segment of eye, NOS]]></category>
		<category><![CDATA[Injection of eye, NOS]]></category>
		<category><![CDATA[Injection of medication in anterior chamber of eye]]></category>
		<category><![CDATA[Injection of orbit, NOS]]></category>
		<category><![CDATA[Injection, NOS]]></category>
		<category><![CDATA[Introduction]]></category>
		<category><![CDATA[Macular retinal edema]]></category>
		<category><![CDATA[Monoclonal antibody preparation]]></category>
		<category><![CDATA[Procedure by method]]></category>
		<category><![CDATA[Procedure on anterior chamber of eye]]></category>
		<category><![CDATA[Procedure on anterior segment of eye]]></category>
		<category><![CDATA[Procedure on body part]]></category>
		<category><![CDATA[Procedure on eye]]></category>
		<category><![CDATA[Procedure on eye and related structures]]></category>
		<category><![CDATA[Procedure on head]]></category>
		<category><![CDATA[Procedure on head AND/OR neck]]></category>
		<category><![CDATA[Procedure on orbital region]]></category>
		<category><![CDATA[Procedure on organ]]></category>
		<category><![CDATA[Procedure on organ system]]></category>
		<category><![CDATA[Procedure, NOS]]></category>
		<category><![CDATA[Retinal disorder, NOS]]></category>
		<category><![CDATA[Retinal edema, NOS]]></category>
		<category><![CDATA[SNOMED RT Concepts]]></category>
		<category><![CDATA[SNOMeSH]]></category>
		<category><![CDATA[Substance]]></category>
		<category><![CDATA[Visual system disorder]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/view/ranibizumab-boosts-reading-speed-in-macular-edema/</guid>
		<description><![CDATA[By David Douglas NEW YORK (Reuters Health) &#8211; In patients with macular edema secondary to retinal vein occlusion (RVO), ranibizumab (Lucentis) improves reading speed, according to researchers. The gains in reading speed seen with six monthly ranizumab injections &#8220;parallel the gains in best-corrected visual acuity observed with ranibizumab treatment,&#8221; Dr. Ivan J. Suner of Retina -]]></description>
		
			<media:content duration="" medium="video">
		<media:title><![CDATA[Ranibizumab boosts reading speed in macular edema]]></media:title>
	<media:description><![CDATA[By David Douglas NEW YORK (Reuters Health) &#8211; In patients with macular edema secondary to retinal vein occlusion (RVO), ranibizumab (Lucentis) improves reading speed, according to researchers. The gains in reading speed seen with six monthly ranizumab injections &#8220;parallel the gains in best-corrected visual acuity observed with ranibizumab treatment,&#8221; Dr. Ivan J. Suner of Retina -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/ranibizumab-boosts-reading-speed-in-macular-edema/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/04/tdc-textless-logo-120.jpg"/>
	<media:keywords><![CDATA[Administration,Administration of medication, NOS,Biological agent, NOS,Disease by body site,Disease of eye, NOS,Disease of head,Disease, NOS,Disorder of orbit, NOS,Disorder of posterior segment of eye,Drug, NOS,Finding, conclusion AND/OR assessment,Generic drug, hormone, vitamin AND/OR blood product,Injection of anterior chamber of eye, NOS,Injection of anterior segment of eye, NOS,Injection of eye, NOS,Injection of medication in anterior chamber of eye,Injection of orbit, NOS,Injection, NOS,Introduction,Macular retinal edema,Monoclonal antibody preparation,Procedure by method,Procedure on anterior chamber of eye,Procedure on anterior segment of eye,Procedure on body part,Procedure on eye,Procedure on eye and related structures,Procedure on head,Procedure on head AND/OR neck,Procedure on orbital region,Procedure on organ,Procedure on organ system,Procedure, NOS,Retinal disorder, NOS,Retinal edema, NOS,SNOMED RT Concepts,SNOMeSH,Substance,Visual system disorder]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
	</channel>
</rss>